A detailed history of Fox Run Management, L.L.C. transactions in Boston Scientific Corp stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 11,762 shares of BSX stock, worth $1.25 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
11,762
Holding current value
$1.25 Million
% of portfolio
0.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $858,155 - $988,008
11,762 New
11,762 $985,000
Q1 2023

May 12, 2023

BUY
$45.09 - $50.03 $200,875 - $222,883
4,455 New
4,455 $222,000
Q2 2022

Aug 12, 2022

BUY
$35.24 - $47.1 $547,559 - $731,839
15,538 Added 309.52%
20,558 $766,000
Q1 2022

May 10, 2022

BUY
$40.9 - $45.1 $205,318 - $226,402
5,020 New
5,020 $222,000
Q4 2021

Feb 09, 2022

SELL
$38.07 - $44.87 $440,584 - $519,280
-11,573 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $84,439 - $93,962
-2,048 Reduced 15.04%
11,573 $502,000
Q2 2021

Aug 05, 2021

BUY
$38.58 - $44.24 $525,498 - $602,593
13,621 New
13,621 $582,000
Q4 2020

Feb 08, 2021

SELL
$33.15 - $41.97 $210,601 - $266,635
-6,353 Closed
0 $0
Q3 2020

Oct 29, 2020

BUY
$34.44 - $42.23 $14,809 - $18,158
430 Added 7.26%
6,353 $243,000
Q2 2020

Jul 31, 2020

BUY
$30.19 - $39.11 $178,815 - $231,648
5,923 New
5,923 $208,000
Q2 2018

Jul 17, 2018

SELL
$26.84 - $34.32 $753,586 - $963,602
-28,077 Closed
0 $0
Q1 2018

Apr 17, 2018

SELL
$25.2 - $28.54 $179,499 - $203,290
-7,123 Reduced 20.24%
28,077 $767,000
Q4 2017

Jan 18, 2018

BUY
$24.79 - $29.8 $872,608 - $1.05 Million
35,200
35,200 $873,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $152B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.